Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of IMC-A12 in Islet Cell Cancer

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: October 27, 2008
Last updated: August 12, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 1, 2010